431 related articles for article (PubMed ID: 4307223)
1. Hemodynamic spectrum of vasopressor and vasodilator drugs.
Lewis CM; Weil MH
JAMA; 1969 May; 208(8):1391-8. PubMed ID: 4307223
[No Abstract] [Full Text] [Related]
2. Pharmacology of pressor agents on the systemic circulation.
Ahlquist RP
Semin Drug Treat; 1973; 3(3):231-40. PubMed ID: 4360321
[No Abstract] [Full Text] [Related]
3. [Changes in the hypertensive effects of angiotensin by adrenergic and anti-adrenergic agents].
Schmitt H; Schmitt H
Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):31-46. PubMed ID: 4296394
[No Abstract] [Full Text] [Related]
4. The dilemma of vasopressors and vasodilators in the therapy of shock.
Shoemaker WC; Brown RS
Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813
[No Abstract] [Full Text] [Related]
5. The effect of drugs on the ballistocardiogram.
Deuchar DC
Bibl Cardiol; 1969; 26():6-11. PubMed ID: 4990625
[No Abstract] [Full Text] [Related]
6. The use and misuse of pressor agents.
Smith NT; Corbascio AN
Anesthesiology; 1970 Jul; 33(1):58-101. PubMed ID: 4393417
[No Abstract] [Full Text] [Related]
7. Microphysiology of vasopressors in shock.
Robb HJ
Vasc Surg; 1967 Apr; 1(1):68-75. PubMed ID: 4294984
[No Abstract] [Full Text] [Related]
8. Shock management: Part II. Pharmacologic intervention.
Rice V
Crit Care Nurse; 1985; 5(1):42-6, 48-9, 51-7. PubMed ID: 3920007
[No Abstract] [Full Text] [Related]
9. Effects of pronethalol on the cardiovascular actions of catecholamines during blockade by phenoxybenzamine.
Garrett J; Malafaya-Baptista A; Osswald W
Br J Pharmacol Chemother; 1966 Sep; 27(3):459-67. PubMed ID: 4381965
[No Abstract] [Full Text] [Related]
10. The effect of acidosis and alkalosis on response to vasopressor and vasodilator drugs.
Chaffee CB
J Trauma; 1969 Feb; 9(2):147-8. PubMed ID: 5763334
[No Abstract] [Full Text] [Related]
11. Vasopressors in obstetrics.
Levinson G; Shnider SM
Clin Anesth; 1974; 10(1):77-109. PubMed ID: 4360084
[No Abstract] [Full Text] [Related]
12. [Vasopressor action of some adrenergic amines in animals in experimental cardiac arrest].
Pietrobono P; Bragheri R; Berizzi GF
Acta Anaesthesiol; 1968; 19():Suppl 9:65-72. PubMed ID: 5757555
[No Abstract] [Full Text] [Related]
13. Escape of mesenteric vessels from adrenergic and nonadrenergic vasoconstriction.
Ross G
Am J Physiol; 1971 Nov; 221(5):1217-22. PubMed ID: 4399394
[No Abstract] [Full Text] [Related]
14. The adrenergic blocking activity of N-tert.-butylmethoxamine (butoxamine).
Levy B
J Pharmacol Exp Ther; 1966 Mar; 151(3):413-22. PubMed ID: 4380047
[No Abstract] [Full Text] [Related]
15. Use of vasopressor agents to increase somatic blood flow.
Skinner DB; Camp TF; Austen WG
Arch Surg; 1967 May; 94(5):610-8. PubMed ID: 6025897
[No Abstract] [Full Text] [Related]
16. Pressor effect of beta blocking agents in rats.
Regoli D; Regoli U; Gysling E
Can J Physiol Pharmacol; 1972 Mar; 50(3):207-14. PubMed ID: 4402339
[No Abstract] [Full Text] [Related]
17. The effects of catecholamines on isolated perfused coronary arteries in the dog.
Trinker FR
Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):218-25. PubMed ID: 4358296
[No Abstract] [Full Text] [Related]
18. [Action of various vasoactive amines on the normal and pathological cardiac function, mainly cardiogenic shock].
Moret PR; Megevand R; Gemperle M
Bibl Cardiol; 1966; 17():45-88. PubMed ID: 4287814
[No Abstract] [Full Text] [Related]
19. Dimethyl isopropylmethoxamine: a selective beta-receptor blocking agent.
Levy B
Br J Pharmacol Chemother; 1966 Aug; 27(2):277-85. PubMed ID: 5967366
[No Abstract] [Full Text] [Related]
20. Vasopressors for treating shock.
Moyer JH; Mills LC
Postgrad Med; 1974 Aug; 56(2):172-80. PubMed ID: 4855378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
